DEVELOPMENT OF A MULTIPLEX REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION ASSAY FOR RAPID DISCRIMINATION BETWEEN HEPATITIS E VIRUS GENOTYPES 3 AND 4
-
- Iida Juri
- Japanese Red Cross Hokkaido Block Blood Center
-
- Kobayashi Yu
- Japanese Red Cross Hokkaido Block Blood Center
-
- Sakata Hidekatsu
- Japanese Red Cross Hokkaido Block Blood Center
-
- Matsubayashi Keiji
- Japanese Red Cross Society, Blood Service Headquarters, Central Blood Institute
-
- Sato Shinichiro
- Japanese Red Cross Hokkaido Block Blood Center
-
- Ikuta Katsuya
- Japanese Red Cross Hokkaido Blood Center
-
- Kino Shuichi
- Japanese Red Cross Hokkaido Block Blood Center
Bibliographic Information
- Other Title
-
- E型肝炎ウイルスの遺伝子型3型株および4型株迅速鑑別検査法の開発
Search this article
Abstract
<p>Hepatitis E virus (HEV) is the causative agent of hepatitis E. Highly pathogenic HEV genotype 4 strains are frequently detected, with two cases of transfusion-transmitted hepatitis E confirmed in 2002 and 2004 in Hokkaido, Japan. Therefore, HEV nucleic acid amplification tests (NATs) have been implemented on a trial basis in Hokkaido since January 2005. HEV RNA-positive samples are quantitatively assayed for HEV RNA and are genotyped using phylogenetic analysis, which takes several days. We developed a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) assay to rapidly discriminate between genotypes 3 and 4 (D-PCR). Different fluorescent dyes were used to label specific probes to genotypes 3 and 4. This method required only approximately 4.5 hours for genotyping by D-PCR, and quantification of HEV RNA could be performed simultaneously. The average sensitivity of D-PCR was inferred to be 38 IU/ml for genotype 3 and 68 IU/ml for genotype 4 when using 1 ml of plasma. The genotypes determined by D-PCR for 297 of 340 HEV RNA-positive samples were consistent with those determined by phylogenetic analysis. The D-PCR method established in the present study promptly provides blood donors and medical institutions with useful medical information related to hepatitis E.</p>
Journal
-
- Japanese Journal of Transfusion and Cell Therapy
-
Japanese Journal of Transfusion and Cell Therapy 65 (6), 858-864, 2019-12-20
The Japan Society of Transfusion Medicine and Cell Therapy
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390565134815553920
-
- NII Article ID
- 130007783989
-
- ISSN
- 18830625
- 18813011
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed